C98H126F16N34S4 — CID 161489031
6-(4-cyclohexylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[[2-(trifluoromethyl)-3H-benzimidazol-5-yl]sulfanyl]pyrimidin-4-amine;6-(1-cyclopropylpiperidin-4-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[3-methyl-2-(trifluoromethyl)benzimidazol-5-yl]sulfanylpyrimidin-4-amine;6-[4-(1-fluoro-2-methylpropan-2-yl)piperazin-1-yl]-N-(5-methyl-1H-pyrazol-3-yl)-2-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-6-yl]sulfanylpyrimidin-4-amine;N-(4-methyl-1H-pyrrol-2-yl)-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-2-[[2-(trifluoromethyl)-3H-benzimidazol-5-yl]sulfanyl]pyrimidin-4-amine;molecular hydrogen (PubChem CID 161489031) has the molecular formula C98H126F16N34S4 and a molecular weight of 2212.56 g/mol. Its IUPAC name is 6-(4-cyclohexylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[[2-(trifluoromethyl)-3H-benzimidazol-5-yl]sulfanyl]pyrimidin-4-amine;6-(1-cyclopropylpiperidin-4-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[3-methyl-2-(trifluoromethyl)benzimidazol-5-yl]sulfanylpyrimidin-4-amine;6-[4-(1-fluoro-2-methylpropan-2-yl)piperazin-1-yl]-N-(5-methyl-1H-pyrazol-3-yl)-2-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-6-yl]sulfanylpyrimidin-4-amine;N-(4-methyl-1H-pyrrol-2-yl)-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-2-[[2-(trifluoromethyl)-3H-benzimidazol-5-yl]sulfanyl]pyrimidin-4-amine;molecular hydrogen.
| Compound Name | 6-(4-cyclohexylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[[2-(trifluoromethyl)-3H-benzimidazol-5-yl]sulfanyl]pyrimidin-4-amine;6-(1-cyclopropylpiperidin-4-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[3-methyl-2-(trifluoromethyl)benzimidazol-5-yl]sulfanylpyrimidin-4-amine;6-[4-(1-fluoro-2-methylpropan-2-yl)piperazin-1-yl]-N-(5-methyl-1H-pyrazol-3-yl)-2-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-6-yl]sulfanylpyrimidin-4-amine;N-(4-methyl-1H-pyrrol-2-yl)-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-2-[[2-(trifluoromethyl)-3H-benzimidazol-5-yl]sulfanyl]pyrimidin-4-amine;molecular hydrogen |
|---|---|
| PubChem CID | 161489031 |
| Molecular Formula | C98H126F16N34S4 |
| Molecular Weight | 2212.56 g/mol |
| Exact Mass | 2210.95 |
| IUPAC Name | 6-(4-cyclohexylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[[2-(trifluoromethyl)-3H-benzimidazol-5-yl]sulfanyl]pyrimidin-4-amine;6-(1-cyclopropylpiperidin-4-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[3-methyl-2-(trifluoromethyl)benzimidazol-5-yl]sulfanylpyrimidin-4-amine;6-[4-(1-fluoro-2-methylpropan-2-yl)piperazin-1-yl]-N-(5-methyl-1H-pyrazol-3-yl)-2-[2-(trifluoromethyl)imidazo[1,2-a]pyridin-6-yl]sulfanylpyrimidin-4-amine;N-(4-methyl-1H-pyrrol-2-yl)-6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]-2-[[2-(trifluoromethyl)-3H-benzimidazol-5-yl]sulfanyl]pyrimidin-4-amine;molecular hydrogen |
| SMILES | Cc1c[nH]c(Nc2cc(N3CCN(CC(F)(F)F)CC3)nc(Sc3ccc4nc(C(F)(F)F)[nH]c4c3)n2)c1.Cc1cc(Nc2cc(C3CCN(C4CC4)CC3)nc(Sc3ccc4nc(C(F)(F)F)n(C)c4c3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCN(C(C)(C)CF)CC3)nc(Sc3ccc4nc(C(F)(F)F)cn4c3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCN(C4CCCCC4)CC3)nc(Sc3ccc4nc(C(F)(F)F)[nH]c4c3)n2)n[nH]1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H] |
| InChI | InChI=1S/C26H30F3N9S.C25H27F3N8S.C24H27F4N9S.C23H22F6N8S.10H2/c1-16-13-22(36-35-16)32-21-15-23(38-11-9-37(10-12-38)17-5-3-2-4-6-17)34-25(33-21)39-18-7-8-19-20(14-18)31-24(30-19)26(27,28)29;1-14-11-22(34-33-14)31-21-13-19(15-7-9-36(10-8-15)16-3-4-16)30-24(32-21)37-17-5-6-18-20(12-17)35(2)23(29-18)25(26,27)28;1-15-10-19(34-33-15)30-18-11-21(35-6-8-37(9-7-35)23(2,3)14-25)32-22(31-18)38-16-4-5-20-29-17(24(26,27)28)13-36(20)12-16;1-13-8-17(30-11-13)33-18-10-19(37-6-4-36(5-7-37)12-22(24,25)26)35-21(34-18)38-14-2-3-15-16(9-14)32-20(31-15)23(27,28)29;;;;;;;;;;/h7-8,13-15,17H,2-6,9-12H2,1H3,(H,30,31)(H2,32,33,34,35,36);5-6,11-13,15-16H,3-4,7-10H2,1-2H3,(H2,30,31,32,33,34);4-5,10-13H,6-9,14H2,1-3H3,(H2,30,31,32,33,34);2-3,8-11,30H,4-7,12H2,1H3,(H,31,32)(H,33,34,35);10*1H |
| InChIKey | WFJCBRAHDFQHFI-UHFFFAOYSA-N |
| XLogP | 24.39 |
| TPSA | 368.23 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 152 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2212.56 |
| LogP ≤ 5 | 24.39 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 32 |